13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-14, with 22 holding rows worth $194,900,511.
- Accession
- 0001826434-25-000004
- Filer
- CIK 1826434
- Filed
- 2025-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 22 entries on the cover page, a total value of $194,900,511 stated on the cover page (in dollars after the unit check, H1), rows summing to $194,900,511 with VALUE read as dollars as filed, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Cigna Corporation | 125523100 | COM | 73,905 | $24,314,745 | dollars as filed | |
| MCKESSON CORP COM | 58155Q103 | Stock | 26,944 | $18,133,043 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 234,920 | $16,785,034 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,061,008 | $16,307,693 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 78,812 | $12,553,175 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 37,869 | $12,543,349 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 101,240 | $11,807,621 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 17,844 | $10,561,239 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 89,453 | $10,023,209 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 120,729 | $9,578,639 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 101,859 | $7,770,823 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 95,825 | $6,795,909 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 156,915 | $6,604,552 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 58,145 | $5,149,612 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 32,325 | $5,038,175 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 50,000 | $4,425,500 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 321,802 | $3,871,278 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 150,207 | $3,607,972 | dollars as filed | |
| STEVANATO GROUP S P A ORD SHS | T9224W109 | Stock | 175,681 | $3,587,406 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 83,659 | $3,168,166 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 128,381 | $2,235,113 | dollars as filed | |
| FEMASYS INC | 31447E105 | cs | 30,606 | $38,258 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-25-000004 | this filing | 2025-05-14 | acceptance time not in the bulk data set |